Notice of Change to Funds Available and Award Budget for PAR-16-099 "NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)"

Notice Number: NOT-FD-19-005

Key Dates
Release Date : February 08, 2019

Related Announcements

PAR-16-099

Issued by

U.S. Food and Drug Administration (FDA)

Center for Veterinary Medicine (CVM)

Purpose

The purpose of this Notice is to change the subsections titled "Funds Available" and "Awards Budget" of FDA's PAR-16-099 NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Now Reads:

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations, availability of funding and awardee performance.

FDA/Center for Veterinary Medicine intends to fund up to $2,500,000, for fiscal years 2016, 2017, 2018, 2019, 2020 in support of this grant program.

It is anticipated that up to 30 awards will be made, not to exceed $160,000 in total costs (direct plus indirect), per award, per fiscal year.

Award Budget

Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect): 

YR 01: $160,000

YR 02: $160,000

YR 03: $160,000

YR 04: $160,000

YR 05: $160,000

The total number of years for which federal support has been approved (project period) will be shown in the "Notice of Award." This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

Should Read:

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations, availability of funding and awardee performance.

FDA/Center for Veterinary Medicine intends to fund up to $5,000,000, for fiscal years 2016, 2017, 2018, 2019, 2020 in support of this grant program.

It is anticipated that up to 30 awards will be made, not to exceed $166,000 in total costs (direct plus indirect), per award, per fiscal year.

Award Budget

Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect): 

YR 01: $166,000

YR 02: $166,000

YR 03: $166,000

YR 04: $166,000

YR 05: $166,000

The total number of years for which federal support has been approved (project period) will be shown in the "Notice of Award." This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

Inquiries

Please direct all inquiries to:

Financial/Grants Management Contact(s)Rene Vasquez
Grants Management Specialist
Office of Acquisition & Grants Services (OAGS)
Telephone: 301-796-3546
Email: Rene.Vasquez@fda.hhs.gov

Scientific/Research Contact(s)

Patrick F. McDermott
Center for Veterinary Medicine (CVM)
Telephone: 240-402-0891
Email: patrick.mcdermott@fda.hhs.gov